Inhibition of cell adhesion by anti–P-selectin aptamer: a new potential therapeutic agent for sickle cell disease
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Adhesive interactions between circulating sickle red blood cells (RBCs), leukocytes, and endothelial cells are major pathophysiologic events in sickle cell disease (SCD). To develop new therapeutics that efficiently inhibit adhesive interactions, we generated an anti–P-selectin aptamer and examined its effects on cell adhesion using knockout-transgenic SCD model mice. Aptamers, single-stranded oligonucleotides that bind molecular targets with high affinity and specificity, are emerging as new therapeutics for cardiovascular and hematologic disorders. In vitro studies found that the anti–P-selectin aptamer exhibits high specificity to mouse P-selectin but not other selectins. SCD mice were injected with the anti–P-selectin aptamer, and cell adhesion was observed under hypoxia. The anti–P-selectin aptamer inhibited the adhesion of sickle RBCs and leukocytes to endothelial cells by 90% and 80%, respectively. The anti–P-selectin aptamer also increased microvascular flow velocities and reduced the leukocyte rolling flux. SCD mice treated with the anti–P-selectin aptamer demonstrated a reduced mortality rate associated with the experimental procedures compared with control mice. These results demonstrate that anti–P-selectin aptamer efficiently inhibits the adhesion of both sickle RBCs and leukocytes to endothelial cells in SCD model mice, suggesting a critical role for P-selectin in cell adhesion. Anti–P-selectin aptamer may be useful as a novel therapeutic agent for SCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice
Chang, J., Patton, J. T., Sarkar, A., Ernst, B., Magnani, J. L., & Frenette, P. S. (2010) · Blood · doi:10.1182/blood-2009-12-260513 · Cited by 238
Selectin Blocking Activity of a Fucosylated Chondroitin Sulfate Glycosaminoglycan from Sea Cucumber
Borsig, L., Wang, L., Cavalcante, M. C. M., Cardilo-Reis, L., Ferreira, P. L., Mourąo, P. A. S., Esko, J. D., & Pavąo, M. S. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610560200 · Cited by 187 · cited 1×
“These molecules share an anionic character and inhibit leukocyte adhesion.(32,43) Thus, the”
BackgroundEmbury, S. H. (2004) · Blood · doi:10.1182/blood-2004-02-0713 · Cited by 141 · cited 3×
“Nonetheless, our in vivo studies using SCD mice clearly demonstrate a critical role for P-selectin in sickle RBC adhesion to endothelial cells, which is in agreement with a study by Embury et al.(8) More intriguingly, molecules other than P-selectin, which include fibronectin,(33) von Willebrand factor,(34) CD36 bindi…”
MethodResultHeparin inhibits the flow adhesion of sickle red blood cells to P-selectin
Matsui, N. M., Varki, A., & Embury, S. H. (2002) · Blood · doi:10.1182/blood-2002-02-0626 · Cited by 123
Research works printed but not linked: 45
- Hebbel, 1980, Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity., N Engl J Med, 302, 992, 10.1056/NEJM198005013021803 · DOI · Paper page
- Pan, 1998, Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells., J Biol Chem, 273, 10058, 10.1074/jbc.273.16.10058 · DOI
- Matsui, 2001, P-selectin mediates the adhesion of sickle erythrocytes to the endothelium., Blood, 98, 1955, 10.1182/blood.V98.6.1955 · DOI · Paper page
- Turhan, 2002, Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm., Proc Natl Acad Sci U S A, 99, 3047, 10.1073/pnas.052522799 · DOI · Paper page
- Eppihimer, 1996, Heterogeneity of expression of E- and P-selectins in vivo., Circ Res, 79, 560, 10.1161/01.RES.79.3.560 · DOI · Paper page
- Kato, 2005, Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality., Br J Haematol, 130, 943, 10.1111/j.1365-2141.2005.05701.x · DOI · Paper page
- Blann, 2008, Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype., J Thromb Thrombolysis, 25, 185, 10.1007/s11239-007-0177-7 · DOI
- Steinberg, 2006, Pathophysiologically based drug treatment of sickle cell disease., Trends Pharmacol Sci, 27, 204, 10.1016/j.tips.2006.02.007 · DOI
- Keefe, 2008, Aptamers as candidate therapeutics for cardiovascular indications., Curr Opin Pharmacol, 8, 147, 10.1016/j.coph.2007.12.005 · DOI
- Tuerk, 1990, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase., Science, 249, 505, 10.1126/science.2200121 · DOI · Paper page
- Ng, 2006, Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease., Nat Rev Drug Discov, 5, 123, 10.1038/nrd1955 · DOI · Paper page
- Keefe, 2010, Aptamers as therapeutics., Nat Rev Drug Discov, 9, 537, 10.1038/nrd3141 · DOI · Paper page
- Ryan, 1997, Knockout-transgenic mouse model of sickle cell disease., Science, 278, 873, 10.1126/science.278.5339.873 · DOI · Paper page
- Diener, 2009, Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779., J Thromb Haemost, 7, 1155, 10.1111/j.1538-7836.2009.03459.x · DOI
- Mazo, 1998, Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1., J Exp Med, 188, 465, 10.1084/jem.188.3.465 · DOI · Paper page
- Chiang, 2007, Imaging receptor microdomains on leukocyte subsets in live mice., Nat Methods, 4, 219, 10.1038/nmeth1018 · DOI
- Lipowsky, 1978, Application of the “two-slit” photometric technique to the measurement of microvascular volumetric flow rates., Microvasc Res, 15, 93, 10.1016/0026-2862(78)90009-2 · doi:10.1016/0026-2862(78)90009-2
- Lipowsky, 1980, In vivo measurements of “apparent viscosity” and microvessel hematocrit in the mesentery of the cat., Microvasc Res, 19, 297, 10.1016/0026-2862(80)90050-3 · DOI · Paper page
- Becker, 2000, Digital video-imaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis., J Immunol Methods, 240, 23, 10.1016/S0022-1759(00)00165-4 · doi:10.1016/s0022-1759(00)00165-4
- French, 1997, Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition., Blood, 89, 4591, 10.1182/blood.V89.12.4591 · DOI · Paper page
- Kaul, 2000, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice., J Clin Invest, 106, 411, 10.1172/JCI9225 · DOI · Paper page
- Setty, 1996, Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease., Blood, 88, 2311, 10.1182/blood.V88.6.2311.bloodjournal8862311 · DOI · Paper page
- Russell, 2003, Low venular shear rates promote leukocyte-dependent recruitment of adherent platelets., Am J Physiol Gastrointest Liver Physiol, 284, G123, 10.1152/ajpgi.00303.2002 · DOI · Paper page
- Turhan, 2004, Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes., Blood, 103, 2397, 10.1182/blood-2003-07-2209 · DOI · Paper page
- Finnegan, 2007, Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion., Am J Physiol Heart Circ Physiol, 293, H1038, 10.1152/ajpheart.01054.2006 · DOI
- Lutty, 2002, Mechanisms for sickle red blood cell retention in choroid., Curr Eye Res, 25, 163, 10.1076/ceyr.25.3.163.13481 · DOI
- Hebbel, 2004, The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy., Microcirculation, 11, 129, 10.1080/mic.11.2.129.151 · doi:10.1080/mic.11.2.129.151 · Paper page
- McEver, 1995, Leukocyte trafficking mediated by selectin-carbohydrate interactions., J Biol Chem, 270, 11025, 10.1074/jbc.270.19.11025 · DOI · Paper page
- Varki, 1997, Selectin ligands: will the real ones please stand up?, J Clin Invest, 100, S31
- Nelson, 1993, Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation., Blood, 82, 3253, 10.1182/blood.V82.11.3253.3253 · DOI · Paper page
- Wautier, 1986, Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium., J Lab Clin Med, 107, 210
- Wick, 1987, Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow., J Clin Invest, 80, 905, 10.1172/JCI113151 · DOI
- Sugihara, 1992, Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells., Blood, 80, 2634, 10.1182/blood.V80.10.2634.2634 · DOI · Paper page
- Swerlick, 1993, Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium., Blood, 82, 1891, 10.1182/blood.V82.6.1891.1891 · DOI · Paper page
- Udani, 1998, Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin., J Clin Invest, 101, 2550, 10.1172/JCI1204 · DOI · Paper page
- Chang, 2008, Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion., Blood, 111, 915, 10.1182/blood-2007-04-084061 · DOI · Paper page
- Francis, 1992, Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease., J Natl Med Assoc, 84, 611
- Wagner, 2008, The vessel wall and its interactions., Blood, 111, 5271, 10.1182/blood-2008-01-078204 · DOI · Paper page
- Orbach, 2004, Intravenous immunoglobulin and the kidney–a two-edged sword., Semin Arthritis Rheum, 34, 593, 10.1016/j.semarthrit.2004.06.003 · DOI
- Pendergrast, 2005, Nucleic acid aptamers for target validation and therapeutic applications., J Biomol Tech, 16, 224
- Okpala, 2006, Leukocyte adhesion and the pathophysiology of sickle cell disease., Curr Opin Hematol, 13, 40, 10.1097/01.moh.0000190108.62414.06 · DOI
- Gilbert, 2007, First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers., Circulation, 116, 2678, 10.1161/CIRCULATIONAHA.107.724864 · DOI · Paper page
- Knobl, 2009, Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura., Transfusion, 49, 2181, 10.1111/j.1537-2995.2009.02232.x · doi:10.1111/j.1537-2995.2009.02232.x
- Dyke, 2006, First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity., Circulation, 114, 2490, 10.1161/CIRCULATIONAHA.106.668434 · DOI · Paper page
- Chan, 2008, A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor., J Thromb Haemost, 6, 789, 10.1111/j.1538-7836.2008.02932.x · DOI
Cited by
Crizanlizumab for the prevention of pain crises in sickle cell disease.
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T. H., Knight-Madden, J., Alvarez, O. A., Gordeuk, V. R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611770 · Cited by 914
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Aptamers from Cell-Based Selection for Bioanalytical Applications
Tan, W., Donovan, M. J., & Jiang, J. (2013) · Chemical Reviews · doi:10.1021/cr300468w · Cited by 649
Selectins: initiators of leucocyte adhesion and signalling at the vascular wall
McEver, R. P. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv154 · Cited by 575
P-selectin promotes neutrophil extracellular trap formation in mice
Etulain, J., Martinod, K., Wong, S. L., Cifuni, S. M., Schattner, M., & Wagner, D. D. (2015) · Blood · doi:10.1182/blood-2015-01-624023 · Cited by 554
Metadata
- Authors
- Gutsaeva, D. R., Parkerson, J. B., Yerigenahally, S. D., Kurz, J. C., Schaub, R. G., Ikuta, T., & Head, C. A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-01-13
- Volume
- 117
- Issue
- 2
- Pages
- 727-735
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2002783428
- Cited by
- 144
- References
- 4
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of cell adhesion by anti–P-selectin aptamer: a new potential therapeutic agent for sickle cell disease. https://app.cochat.ai/papers/10.1182/blood-2010-05-285718
- The paper
- Gutsaeva, D. R., Parkerson, J. B., Yerigenahally, S. D., Kurz, J. C., Schaub, R. G., Ikuta, T., & Head, C. A. (2011). Inhibition of cell adhesion by anti–P-selectin aptamer: a new potential therapeutic agent for sickle cell disease. Blood. https://doi.org/10.1182/blood-2010-05-285718
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.